Towards a better understanding of the molecular mechanisms involved in sunlight-induced melanoma

Journal of Biomedicine and Biotechnology

Volumn 2005, Issue 1, 2005, Pages 57-61

  Williams, Mandy ^a   Ouhtit, Allal ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN MDM2; PROTEIN P14ARF; PROTEIN P16INK4A; PROTEIN P21; PROTEIN P53;

CDK4 GENE; CDKN2A GENE; CELL CYCLE; CHROMOSOME 12Q; CHROMOSOME 9P; CYTOGENETICS; GENE; GENE LOCUS; GENE MAPPING; GENE MUTATION; HUMAN; MELANOMA; NONHUMAN; RADIATION EXPOSURE; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SOLAR RADIATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

ANIMALIA; PYRONIA TITHONUS;

EID: 22544441863     PISSN: 11107243     EISSN: None     Source Type: Journal    
DOI: 10.1155/JBB.2005.57     Document Type: Review

References (51)

1. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340(17):1341-1348.
2. Welch DR, Goldberg SF. Molecular mechanisms controlling human melanoma progression and metastasis. Pathobiology. 1997;65(6):311-330.
3. Forrest APM, Carter DC, MacLeod IB. Principles and Practice of Surgery. 3rd ed. Edinburgh, UK: Churchill Livingstone; 1995.
4. Bressac-de-Paillerets B, Avril MF, Chompret A, Demenais F. Genetic and environmental factors in cutaneous malignant melanoma. Biochimie. 2002;84(1):67-74.
5. Kannan K, Sharpless NE, Xu J, O'Hagan RC, Bosenberg M, Chin L. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc Natl Acad Sci USA. 2003;100(3):1221-1225.
6. Omholt K, Platz A, Kanter L, Ringborg U, Hansson J. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin Cancer Res. 2003;9(17):6483-6488.
7. Pollock PM, Trent JM. The genetics of cutaneous melanoma. Clin Lab Med. 2000;20(4):667-690.
8. Cowan JM, Francke U. Cytogenetic analysis in melanoma and nevi. Cancer Treat Res. 1991;54:3-16.
9. Healy E, Belgaid CE, Takata M, et al. Allelo-types of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res. 1996;56(3):589-593.
10. Castellano M, Parmiani G. Genes involved in melanoma: an overview of INK4a and other loci. Melanoma Res. 1999;9(5):421-432.
11. Chin L, Merlino G, DePinho RA. Malignant melanoma: modern black plague and genetic black box. Genes Dev. 1998;12(22):3467-3481.
12. Larsen CJ. p16INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression. Oncogene. 1996;12(10):2041-2044.
13. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 1995;83(6): 993-1000.
14. Sharpless NE, DePinho RA. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev. 1999;9(1):22-30.
15. Bressac-de-Paillerets B, Avril MF, Chompret A, Demenais F. Genetic and environmental factors in cutaneous malignant melanoma. Biochimie. 2002;84(1):67-74.
16. Fears TR, Scotto J, Schneiderman MA. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. Am J Epidemiol. 1977;105(5):420-427.
17. Ley RD, Applegate LA, Padilla RS, Stuart TD. Ultraviolet radiation-induced malignant melanoma in Monodelphis domestica. Photochem Photobiol. 1989;50(5):1-5.
18. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001;12(1):69-82.
19. IARC. Solar and Ultraviolet Radiation, vol. 55 of IARC monographs on the evaluation of carcinogenic risk to humans. Lyon: International Agency for Research on Cancer; 1992.
20. Wang SQ, Setlow R, Berwick M, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol. 2001;44(5):837-846.
21. Noonan FP, Recio JA, Takayama H, et al. Neonatal sunburn and melanoma in mice. Nature. 2001;413(6853):271-272.
22. Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene. 2003;22(20):3099-3112.
23. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA. 1991;88(22):10124-10128.
24. Peris K, Chimenti S, Fargnoli MC, Valeri P, Kerl H, Wolf P. UV fingerprint CDKN2a but no p14ARF mutations in sporadic melanomas. J Invest Dermatol. 1999;112(5):825-826.
25. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell. 1992;68(1):157-166.
26. Pavey S, Conroy S, Russell T, Gabrielli B. Ultraviolet radiation induces p16CDKN2A expression in human skin. Cancer Res. 1999;59(17):4185-4189.
27. Chazal M, Marionnet C, Michel L, et al. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation. Oncogene. 2002;21(17):2652-2661.
28. Milligan A, Gabrielli BG, Clark JM, Hayward NK, Ellem KA. Involvement of p16CDKN2A in cell cycle delays after low dose UV irradiation. Mutat Res. 1998;422(1):43-53.
29. van der Velden PA, Metzelaar-Blok JA, Bergman W, et al. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma. Cancer Res. 2001;61(13):5303-5306.
30. Castellano M, Pollock PM, Walters MK, et al. CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Res. 1997;57(21):4868-4875.
31. Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. Apoptosis in proliferating, senescent, and immortalized keratinocytes. J Biol Chem. 1999;274(33):23358-23367.
32. Ghiorzo P, Bianchi Scarr GB. Genetics of melanoma susceptibility. Forum (Genova). 2003;13(2):114-126.
33. Zuo L, Weger J, Yang Q, et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet. 1996;12(1):97-99.
34. Soufir N, Avril MF, Chompret A, et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet. 1998;7(2):209-216.
35. Wolfel T, Hauer M, Schneider J, et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 1995;269(5228):1281-1284.
36. Ouhtit A, Muller HK, Davis D, Ullrich SE, McConkey D, Ananthaswamy HN. Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin. Am J Pathol. 2000;156(1):201-207.
37. Ouhtit A, Corny A, Muller K, Hill LL, Owen-Schaub L, Ananthaswamy HN. Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis. Am J Pathol. 2000;157(6):1975-1981.
38. Hill LL, Ouhtit A, Loughlin S, Kripke ML, Ananthaswamy HN, Owen-Schaub LB. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science. 1999;285(5429):898-900.
39. Qin JZ, Chaturvedi V, Denning MF, et al. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes. Oncogene. 2002;21(19):2991-3002.
40. Bowen AR, Hanks AN, Allen SM, Alexander A, Diedrich MJ, Grossman D. Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J Invest Dermatol. 2003;120(1):48-55.
41. Honda R, Yasuda H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 1999;18(1):22-27.
42. Piccinin S, Doglioni C, Maestro R, et al. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression. Int J Cancer. 1997;74(1):26-30.
43. Randerson-Moor JA, Harland M, Williams S, et al. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet. 2001;10(1):55-62.
44. Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer. 2003; 3(8):559-570.
45. van Elsas A, Zerp SF, van der Flier S, et al. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol. 1996;149(3):883-893.
46. Wei W, Hemmer RM, Sedivy JM. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol Cell Biol. 2001;21(20):6748-6757.
47. Benanti JA, Galloway DA. Normal human fibroblasts are resistant to RAS-induced senescence. Mol Cell Biol. 2004;24(7):2842-2852.
48. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996;85(1):27-37.
49. Chin L, Pomerantz J, Polsky D, et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 1997;11(21):2822-2834.
50. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33(1):19-20.
51. Laud K, Kannengiesser C, Avril MF, et al. BRAF as a melanoma susceptibility candidate gene? Cancer Res. 2003;63(12):3061-3065.